|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| C07H 19/06 | (2006.01) | ||
| C07H 19/14 | (2006.01) | ||
| A61K 31/7064 | (2006.01) | ||
| A61K 31/7076 | (2006.01) | ||
| A61P 1/16 | (2006.01) |
| (11) | Number of the document | 3122752 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15715934.4 |
| Date of filing the European patent application | 2015-03-26 | |
| (97) | Date of publication of the European application | 2017-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation | 2021-11-10 |
| (86) | Number | PCT/US2015/022621 |
| Date | 2015-03-26 |
| (87) | Number | WO 2015/148746 |
| Date | 2015-10-01 |
| (30) | Number | Date | Country code |
| PCT/CN2014/074294 | 2014-03-28 | WO |
| (72) |
GIRIJAVALLABHAN, Vinay, M. , US
OLSEN, David, B. , US
ZHANG, Zhibo , CN
FU, Jianmin , CN
TANG, Bing-Yu , CN
|
| (73) |
Merck Sharp & Dohme LLC,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 4'-Pakeistųjų nukleozidų dariniai kaip ŽIV atvirkštinės transkriptazės inhibitoriai |
| 4'-SUBSTITUTED NUCLEOSIDE-DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-02-10 | 11 | 289.00 EUR |
| 2026-03-26 |